Clinical Research, Pharma & Healthcare FinancingOculis Hosts R&D Event to Share Pipeline Progress TodayGlobeNewswireApril 15, 2025April 16, 2025 by GlobeNewswireApril 15, 2025April 16, 20250137 Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...